Home/Pipeline/Purgo Pouch

Purgo Pouch

Fracture-Related Infections (FRI)

PreclinicalActive

Key Facts

Indication
Fracture-Related Infections (FRI)
Phase
Preclinical
Status
Active
Company

About Purgo Scientific

Purgo Scientific is a private, preclinical-stage biotech company based in San Diego, founded in 2018. The company is developing the Purgo Pouch, a combination product device designed for localized, sustained antibiotic delivery to treat orthopedic biofilm infections, with an initial target indication of fracture-related infections. With clinical testing planned for 2027 and a foundation of preclinical data from over 140 sheep, the company is addressing a significant unmet need in surgical site infections, which cost the U.S. healthcare system $10 billion annually. Purgo Scientific is positioned in the high-stakes medical device and localized therapeutic delivery market within orthopedics.

View full company profile